7 Common Nuclear Medicine Tests and What They Can Detect

Nuclear medicine uses small amounts of radioactive material, called radiotracers, to show how organs and tissues are working inside the body. Unlike many imaging tests that mainly show structure, nuclear medicine can reveal function, blood flow, metabolism, and disease activity. The radiotracer may be injected, swallowed, or inhaled depending on the test. A special camera then detects the energy released by the tracer and creates images for doctors to review.

Doctors may recommend nuclear medicine tests when they need information that other scans may not fully provide. These tests can help detect heart disease, bone disorders, thyroid problems, kidney function changes, gallbladder disease, infection, inflammation, and certain cancers. Some scans can also show whether treatment is working or whether disease has returned. This article explains seven common nuclear medicine tests and what they can detect, along with what patients may expect during testing.

What is Nuclear Medicine and How Does It Work?

Nuclear medicine is a subspecialty of radiology that utilizes trace amounts of radioactive substances to create images of the body’s internal functions and structures for diagnostic and therapeutic purposes.

Core Mechanics of Functional Imaging

Nuclear medicine is a specialized subspecialty of radiology that introduces trace amounts of radioactive substances into the body to map internal physiological functions and cellular metabolic activity. Traditional radiology modalities—such as standard X-rays, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI)—primarily provide anatomical or structural visualization. They act like a high-resolution photograph of an organ, capturing changes in shape, density, or structural integrity.

In contrast, nuclear medicine functions as molecular or functional imaging. It evaluates how tissues and organs are operating in real time. Rather than waiting for a disease to physically alter the shape or structure of an organ, functional imaging can track cellular abnormalities, blood flow alterations, or enzymatic pathways at a molecular level. This unique capability frequently allows for the detection of pathologies—such as malignant tumors, cardiac ischemia, or neurological disorders—long before any structural damage becomes visible on a standard CT scan or X-ray.

Production and Administration of Radiopharmaceuticals

The execution of a nuclear medicine scan relies entirely on engineered compounds known as radiopharmaceuticals, or radiotracers. These trace compounds are constructed from two distinct chemical building blocks:

The Pharmaceutical Vector: This molecule is chosen based on its biological affinity for a specific organ, tissue type, or metabolic pathway. For instance, the thyroid gland naturally collects iodine to produce hormones, while rapidly growing bone cells rapidly absorb specific phosphate compounds. By using these natural biological pathways, the pharmaceutical can guide the trace package to a targeted location within the body.

The Radionuclide Tag: This is an unstable radioactive isotope attached to the pharmaceutical carrier. As this unstable atom seeks a more stable nuclear state, it decays and emits energy in the form of high-energy gamma rays or positrons. Because these rays easily pass through human tissue, they can be tracked from outside the body.

Routes of Clinical Administration

Depending on the specific organ system under evaluation, clinicians introduce the radiopharmaceutical into the body through one of three primary pathways:

• Intravenous Injection: The most common route, where the radiotracer is delivered directly into a peripheral vein. It enters the systemic circulation, allowing the bloodstream to transport the molecular package to target sites like the heart, skeleton, or brain.

• Oral Ingestion: Used for evaluating the gastrointestinal tract, gastric emptying rates, or specific thyroid therapies. The patient swallows the tracer in either a liquid solution or an encapsulated form.

• Inhalation Administration: To evaluate pulmonary ventilation and look for potential blood clots (pulmonary embolisms), the patient inhales the tracer as a fine gas or aerosolized mist, which fills the lungs’ airways.

Once the radiopharmaceutical accumulates in the target tissue, it emits gamma photons. These outgoing rays are captured by specialized external detection arrays, such as a planar gamma camera or a Positron Emission Tomography (PET) scanner. A powerful computer system processes the location and density of these incoming photons, translating the data into detailed two- or three-dimensional functional maps that reflect the real-time health of the tissue.

Patient Safety and Radiobiological Half-Lives

A frequent concern regarding nuclear medicine procedures is radiation safety. However, these diagnostic protocols are safe and strictly regulated. The total ionizing radiation dose a patient receives from a standard scan is minimal, typically matching or falling below the background radiation doses associated with routine diagnostic CT scans.

Medical teams strictly follow the foundational safety principle known as ALARA (As Low As Reasonably Achievable). This framework ensures that nuclear medicine physicians and technologists use the absolute minimum mass of radioactive material necessary to generate clear diagnostic images.

The high safety profile of these radiotracers is achieved by balancing two distinct clearance mechanisms:

Physical Half-Life

Radionuclides used for diagnostic imaging are specifically selected for their short physical half-lives—the time required for half of the radioactive atoms to decay naturally into a stable, non-radiative state. For common imaging agents like Technetium-99m or Fluorine-18 , this window spans only a few hours. This ensures that the material’s radioactivity drops rapidly after the scan is complete.

Biological Clearance

In tandem with natural physical decay, the human body actively processes and excretes the pharmaceutical component. The kidneys and liver clear the tracer molecules from the bloodstream, expelling them through urine or stool within 24 to 48 hours. Patients are routinely instructed to drink plenty of fluids immediately following a scan to help speed up this natural elimination process.

Furthermore, because these tracers are administered in microscopic, sub-pharmacological amounts, allergic reactions are exceptionally rare. The chemical compositions do not trigger the hypersensitivity reactions or kidney strain sometimes linked to the heavy, iodine-based contrast dyes used in conventional CT imaging. Decades of clinical performance demonstrate that nuclear medicine remains a highly safe and essential tool in modern diagnostic medicine.

What Diseases Can 7 Common Nuclear Medicine Tests Detect?

These 7 common nuclear medicine tests can detect a vast spectrum of diseases, including various cancers, heart conditions like coronary artery disease, neurological disorders such as Alzheimer’s, bone fractures and infections, thyroid gland dysfunctions, kidney blockages, and gallbladder inflammation. By providing a window into the functional processes of the body, these scans offer critical diagnostic information that helps physicians stage diseases, monitor treatment effectiveness, and guide patient care with exceptional precision. Each test uses a specific radiotracer tailored to a particular organ or biological process, allowing for targeted and highly sensitive evaluations.

Next, we will explore each of these seven key tests in detail, outlining the specific conditions they are designed to identify. From pinpointing cancerous tumors with a PET scan to assessing blood flow in the heart with a myocardial perfusion scan, these procedures represent the forefront of diagnostic imaging. Understanding what each test reveals is essential for appreciating the profound impact of nuclear medicine on diagnosing and managing complex health issues across virtually every medical specialty, from oncology and cardiology to endocrinology and urology.

Positron Emission Tomography (PET) Scan

A Positron Emission Tomography (PET) scan measures cellular metabolism by tracking how tissues absorb radiopharmaceuticals. The most common tracer used is Fluorodeoxyglucose (FDG), a glucose molecule tagged with radioactive Fluorine-18 ($^{18}\text{F}$). Because metabolic alterations occur before structural modifications, PET is a highly sensitive tool for early disease detection.

Oncology (Cancer Detection)

Malignant tumors have an accelerated metabolic rate and consume glucose much faster than healthy tissue. When injected, FDG accumulates heavily within these high-activity zones, creating brilliant bright zones or “hot spots” on the scan. This allows oncologists to differentiate between benign and malignant masses, pinpoint exact margins for biopsy or surgical resection, accurately stage cancer by discovering hidden metastases, and monitor whether tumors are responding to chemotherapy.

Cardiology (Heart Conditions)

In cardiac care, PET scans evaluate myocardial viability by mapping both regional blood perfusion and glucose consumption. After a patient experiences a myocardial infarction (heart attack), a PET scan can distinguish between permanently scarred, dead tissue and stunned, hibernating tissue that is still alive. Identifying these viable areas helps cardiologists determine if high-risk interventions, such as coronary artery bypass grafting (CABG) or angioplasty, will successfully restore heart function.

Neurology (Brain Disorders)

The brain relies on glucose as its primary fuel source. By mapping variations in cerebral glucose metabolism, neuro-PET scans assist in the early diagnosis of complex central nervous system conditions:

• Dementia Differentiation: It can pinpoint the distinct, localized drops in temporoparietal metabolism that characterize Alzheimer’s disease, separating it from frontotemporal dementia or vascular dementia.

• Epileptic Focus Localization: For patients with severe epilepsy who do not respond to medication, a PET scan performed between seizures can identify hypometabolic zones—the exact regions where seizures originate—providing a map for surgical removal.

Single-Photon Emission Computed Tomography (SPECT) Scan

Single-Photon Emission Computed Tomography (SPECT) shares functional similarities with PET but utilizes different radiopharmaceuticals, such as Technetium-99m, Thallium-201, or Iodine-123. These tracers emit single gamma photons directly rather than positrons. The gamma camera rotates 360 degrees around the patient, capturing photon coordinates that a computer cross-references to generate 3D cross-sectional slices of blood flow (perfusion) through tissues.

Cardiology (Coronary Artery Disease)

SPECT is the primary modality used for Nuclear Stress Testing. By injecting a tracer like Tc-99m sestamibi while the patient is at rest and again while the heart is working hard on a treadmill, cardiologists can compare blood flow across different conditions. This test uncovers areas of restricted blood flow (ischemia) caused by blocked or narrowed coronary arteries.

Neurology (Cerebral Blood Perfusion)

SPECT scans map regional cerebral blood flow, which serves as a direct indicator of brain activity. This is highly useful for identifying dead tissue following an ischemic stroke, mapping hidden damage from traumatic brain injuries (TBIs), and locating focus points for surgical treatment of epilepsy.

Oncology and Orthopedics (Skeletal Imaging)

When combined with conventional CT imaging (SPECT/CT), this test can pinpoint small bone lesions. It can find hidden stress fractures that do not show up on normal X-rays, isolate deep bone infections (osteomyelitis), and identify early-stage bone metastases from primary breast or prostate cancers.

The Skeletal Bone Scan

A nuclear medicine bone scan is a highly sensitive diagnostic test that screens the entire skeletal system for metabolic changes. The test uses a technetium-labeled diphosphonate tracer, which mimics the body’s natural bone-building materials and binds directly to hydroxyapatite crystals in areas undergoing active repair or breakdown.

Cancer Metastasis Screening

Many aggressive cancers, including breast, prostate, lung, and kidney cancers, have a tendency to metastasize to the skeleton. As tumor cells invade the bone, they trigger a defensive remodeling response. The radiotracer collects rapidly in these hyperactive repair zones, revealing skeletal metastases as distinct hot spots months before traditional X-rays show any structural structural damage.

Stress and Occult Fracture Detection

For athletes suffering from persistent pain, a bone scan can identify tiny stress fractures or hidden “occult” breaks. These micro-fractures often remain invisible on conventional X-rays because the bone’s shape hasn’t changed. The scan catches the increased metabolic activity of osteoblasts working to mend the microscopic cracks right away.

Pinpointing Osteomyelitis

Diagnosing deep bone infections (osteomyelitis) is a complex medical challenge. A bone scan can isolate these dangerous infections by tracking the surge in blood flow and rapid bone turnover triggered by the body’s local inflammatory response, allowing doctors to start targeted IV antibiotic therapy before permanent bone destruction occurs.

Thyroid Scan and Uptake Test

The thyroid scan and uptake test is a targeted endocrine panel that evaluates both the physical shape and functional performance of the thyroid gland. The protocol takes advantage of the thyroid’s natural dependency on iodine, introducing either Iodine-123 or Technetium-99m into the patient’s system.

The Radioactive Iodine Uptake (RAIU) Test

The RAIU portion of the test measures the overall functional capacity of the thyroid gland. The patient swallows a precise dose of radioactive iodine, and a external probe is placed over the neck at 4 to 6-hour and 24-hour intervals to calculate the exact percentage of iodine absorbed from the blood.

• Elevated Uptake: An unusually high uptake percentage indicates hyperthyroidism, a condition where the gland is overproducing hormones, which is common in Graves’ disease.

• Depressed Uptake: A very low uptake percentage suggests hypothyroidism, where the gland is underactive, or thyroiditis, which is active inflammation that prevents iodine absorption.

The Thyroid Scintigraphy Scan

While the uptake test calculates global function, the scan generates a visual map of the gland using a gamma camera. This allows endocrinologists to categorize thyroid nodules based on their functional behavior:

• Hot Nodules: Autonomously functioning tissue lumps that absorb the tracer heavily and overproduce thyroid hormones. These are rarely malignant.

• Cold Nodules: Non-functional tissue lumps that appear as blank zones on the image. Because cold nodules have a significantly higher risk of containing thyroid cancer, they require follow-up with a fine-needle aspiration biopsy.

Myocardial Perfusion Imaging (MPI)

Myocardial Perfusion Imaging (MPI), or a nuclear stress test, is a cornerstone of non-invasive cardiology. It maps the distribution of coronary blood flow to the heart muscle during rest and under physical stress.

Step 1: Baseline Resting Capture

The patient receives an intravenous injection of a technetium-based perfusion tracer (such as sestamibi or tetrofosmin) while resting quietly. The tracer travels through the coronary arteries and binds to the heart muscle cells in direct proportion to local blood flow. A gamma camera captures the baseline images, providing a clear map of resting blood flow.

Step 2: Peak Stress Capture

The patient is then placed under physical stress, either by walking on a treadmill according to a standardized protocol or through an IV medication (like regadenoson or adenosine) that dilates the coronary arteries to simulate exercise. At peak cardiac stress, a second dose of the radiotracer is injected, and the camera captures images of the heart working at its maximum capacity.

Step 3: Comparative Analysis

Cardiologists analyze the rest and stress image sets side-by-side to determine health status:

• Ischemic Profile (Reversible Defect): An area that shows normal, healthy blood flow at rest but displays a significant drop in tracer absorption during stress indicates a severe blockage or narrowing in a coronary artery. This tissue is at risk but can be saved with stenting or bypass surgery.

• Infarcted Profile (Fixed Defect): If a section of the heart muscle shows a severe lack of tracer absorption on both the rest and stress images, it indicates a permanent scar from a past heart attack. This non-viable tissue will not benefit from revascularization surgery.

Renal (Kidney) Scintigraphy

A renal scan, or renogram, evaluates kidney health by tracking blood flow, filtration capacity, and clearance rates through the urinary tract in real time. It typically uses specialized tracers like Tc-99m MAG3 or Tc-99m DTPA.

Investigating Renal Artery Stenosis

Renal artery stenosis is a narrowing of the main arteries that deliver blood to the kidneys, which can trigger severe, treatment-resistant hypertension. To diagnose this condition, clinicians perform a specialized renal scan paired with an oral dose of an ACE inhibitor (like captopril). If the medication causes a sharp drop in blood filtration in one kidney, it confirms stenosis in that specific artery.

Mapping Urinary Tract Obstructions

When kidney stones, structural abnormalities, or tumors block the urinary tract, urine backs up and causes painful swelling in the kidneys (hydronephrosis). A renal scan tracks the movement of the tracer as it is filtered into the kidney pelvis and drains into the bladder. If the tracer pools in the kidney and fails to clear even after administering a powerful diuretic like furosemide, it confirms a physical blockage that requires surgical intervention.

Monitoring Kidney Transplants

Following a kidney transplant, renal scans provide a non-invasive way to monitor the new organ. It can immediately confirm if the surgical attachments are providing adequate blood flow, measure how effectively the new kidney is producing urine, and quickly identify early signs of transplant rejection or internal urine leaks.

Gallbladder HIDA Scan

A Hepatobiliary Iminodiacetic Acid (HIDA) scan, also known as cholescintigraphy, tracks the production and movement of bile from the liver through the biliary ducts and into the gallbladder and small intestine. The test uses an intravenously injected technetium-labeled tracer that mimics bilirubin, allowing doctors to watch the digestive tract operate in real time.

Diagnosing Acute Cholecystitis

Acute cholecystitis is a sudden, painful inflammation of the gallbladder, usually caused by a gallstone becoming lodged in the cystic duct. During a HIDA scan, the liver cells absorb the tracer and excrete it into the bile ducts normally. However, if the cystic duct is blocked, the tracer cannot enter the gallbladder. If the liver and small intestine light up on the scan but the gallbladder remains completely blank after an hour, it confirms a diagnosis of acute cholecystitis.

Measuring Biliary Dyskinesia

For patients suffering from chronic, unexplained abdominal pain without visible gallstones on an ultrasound, a HIDA scan can measure the gallbladder ejection fraction. The technologist administers a synthetic hormone called cholecystokinin (CCK), which forces the gallbladder to contract and empty its stored bile. If the gallbladder expels an unusually low percentage of the tracer, it indicates a functional coordination disorder known as biliary dyskinesia, which can be cured by surgically removing the gallbladder.

Detecting Post-Operative Bile Leaks

Following a gallbladder removal surgery (cholecystectomy) or a traumatic liver injury, bile can sometimes leak into the abdominal cavity. A HIDA scan is the most sensitive tool for catching this complication. It tracks the tracer as it escapes the normal bile ducts and pools in open spaces inside the abdomen, allowing surgical teams to pinpoint the leak and fix it right away.

What Else Should You Know About Nuclear Medicine Procedures?

Beyond identifying specific diseases, understanding nuclear medicine involves knowing about patient preparation, how it compares to other imaging, the specificity of its agents, and its technological evolution. Furthermore, these aspects provide a comprehensive view of the field, highlighting its unique role in modern diagnostics and therapeutics by focusing on physiological function rather than just anatomical structure.

This functional insight is achieved through carefully selected radiopharmaceuticals and advanced imaging systems that continue to evolve, offering greater precision and new clinical applications that are transforming patient care, particularly in oncology and neurology.

Clinical Patient Preparation Protocols

Proper patient preparation is essential for a nuclear medicine scan. Because these tests measure real-time metabolic and physiological pathways, failing to follow preparation guidelines can cause healthy tissue to absorb the radiotracer incorrectly, ruining the scan’s accuracy.

Metabolic Stabilization (Fasting and Hydration)

For procedures evaluating the heart or digestive system—especially oncological PET scans utilizing Fluorodeoxyglucose (FDG)—patients must typically fast for 4 to 12 hours before the appointment. Fasting stabilizes blood glucose and lowers systemic insulin levels. If a patient eats before an FDG-PET scan, insulin spikes and forces the radioactive sugar into healthy skeletal muscles instead of letting it pool in malignant tumor cells.

Drinking plenty of plain water is highly encouraged, as it keeps the patient well-hydrated, ensures steady blood flow to distribute the tracer, and helps the kidneys flush out any remaining radioactive material after the scan is complete.

Chemical and Stimulant Interventions

Certain prescription medications and dietary stimulants must be carefully managed or temporarily paused:

• Cardiac Stress Testing: Patients must strictly avoid caffeine, nicotine, chocolate, and decaffeinated beverages for at least 24 hours prior to the test. Caffeine directly blocks adenosine receptors in the heart, preventing medications like regadenoson from properly dilating the coronary arteries during a pharmacological stress test.

• Medication Restrictions: Medications like beta-blockers may need to be paused because they artificially suppress the heart rate, while thyroid supplements or iodine-heavy cough syrups must be withheld before a thyroid scan to keep from oversaturating the gland with non-radioactive iodine.

Physical Comfort and Patient Safety

Patients are advised to wear loose, comfortable clothing free of metal components such as zippers, underwires, snaps, or heavy buttons, as metal dense enough to block gamma rays can create blank spots or artifacts on the final image. All jewelry and piercings should be removed.

Additionally, it is absolutely critical for patients who are pregnant, suspect they might be pregnant, or are currently breastfeeding to notify their medical team immediately. While diagnostic doses are low, fetal tissue is highly sensitive to radiation, and breastfeeding mothers will receive strict instructions on when it is safe to resume nursing based on how long it takes the specific tracer to clear their breastmilk.

Modality Matrix: Nuclear Medicine vs. CT vs. MRI

Understanding when to utilize nuclear medicine versus structural imaging modalities like Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) comes down to a clear clinical question: Are you investigating what an organ looks like, or how it is actually performing?

The Core Diagnostic Split

Conventional radiology modalities (CT and MRI) focus entirely on anatomical detail. They generate high-contrast images of the body’s physical structures, mapping physical borders, density variations, and structural defects.

Nuclear medicine, by contrast, maps molecular physiology. It tracks cellular metabolism, chemical pathways, and regional blood flow, identifying functional abnormalities long before a disease grows large enough to physically alter the shape, size, or appearance of an organ.

Modality Profiles and Clinical Strengths

Targeted Biological Architecture of Radiopharmaceuticals

The clinical precision of nuclear medicine relies on matching a specific radioactive tag with a dedicated chemical carrier. This combination ensures the tracer targets only the exact organ system or cellular pathway under investigation.

Fluorodeoxyglucose

• Biological Target: Cellular glucose consumption pathways.

• Mechanism: Malignant cancer cells and highly active brain neurons consume glucose at an accelerated rate. Because FDG mimics a standard glucose molecule, cells pull it in via glucose transporter proteins. Once inside, the cell chemically alters the FDG, trapping it there. This creates brilliant bright spots on a PET scan that highlight hyper-metabolic tumors or overactive epileptic zones.

Technetium-99m Medronate

• Biological Target: Hydroxyapatite crystals within the skeletal matrix.

• Mechanism: Medronate is a diphosphonate molecule that binds directly to calcium phosphate structures in bone tissue. When the skeleton is injured, infected, or invaded by traveling cancer cells, osteoblasts rush to repair the site, rapidly building new bone. The injected $\text{Tc}-99\text{m}$-MDP settles heavily in these active remodeling zones, revealing hidden stress fractures or bone metastases.

Radioactive Iodine

• Biological Target: Thyroid follicular cells.

• Mechanism: The thyroid gland is the only organ in the human body that actively traps and concentrates iodine, using it as a raw material to manufacture thyroid hormones. Because the body cannot tell the difference between stable iodine and radioactive isotopes, doctors can use low-dose Iodine-123 to clearly map thyroid nodules, or high-dose Iodine-131 to deliver targeted radiation that destroys thyroid cancer cells while leaving the rest of the body safe.

Next-Generation Technological Evolutions

Modern nuclear medicine is moving away from standalone scanners, driven by advanced engineering, hybrid imaging hardware, artificial intelligence, and targeted molecular therapies.

Hybrid Imaging Systems (PET/CT and PET/MRI)

Historically, interpreting a nuclear medicine scan was challenging because functional images show metabolic “hot spots” but lack crisp anatomical landmarks. Today, hybrid imaging solves this problem by combining two separate scanning technologies into a single physical machine:

• PET/CT: This standard of care in oncology takes a functional PET scan and overlays it directly onto a high-speed anatomical CT scan during a single patient session. This fusion allows a radiologist to spot a hyper-metabolic nodule on the PET scan and instantly read its exact millimeter coordinates and relationship to nearby blood vessels on the CT scan.

• PET/MRI: The latest evolution in hybrid imaging, PET/MRI replaces the CT component with high-contrast magnetic resonance. This combination is highly valuable for brain imaging and soft-tissue pelvic cancers, merging metabolic data with exceptional soft-tissue detail while lowering the patient’s overall radiation exposure by avoiding CT X-rays.

The Rise of Theranostics

One of the most revolutionary movements in modern oncology is theranostics, a strategy that combines targeted diagnostics and therapeutics into a single molecular platform.

Artificial Intelligence Integration

Machine learning and neural networks are reshaping nuclear medicine workflows from start to finish. Advanced AI algorithms process raw scan data to filter out background noise, allowing imaging teams to reduce the initial radiopharmaceutical dose or cut total scan times in half without losing image quality.

Furthermore, AI diagnostic software screens massive pixel datasets to uncover subtle metabolic patterns that might escape the human eye, helping doctors catch conditions like Alzheimer’s disease years earlier and personalizing cancer therapies with unprecedented precision.

Conclusion

Nuclear medicine tests can provide detailed information about how the body functions, not just how it looks. They may help doctors diagnose disease earlier, evaluate organ function, monitor treatment response, or find problems that are difficult to see with standard imaging. The amount of radiation used is usually low and carefully controlled, but the benefits and risks should be discussed with a healthcare provider, especially during pregnancy or breastfeeding. Understanding why a specific nuclear medicine test is recommended can make the process feel clearer and less overwhelming.

Read more: Lone Star Tick Bite: Symptoms, Risks, and When to See a Doctor

Frequently Asked Questions

1. What is nuclear medicine?

Nuclear medicine is a medical imaging field that uses small amounts of radioactive tracers to examine how organs and tissues function. The tracer travels through the body and collects in specific areas depending on the test. A special camera detects the tracer and creates images that help doctors identify disease or abnormal activity. Some nuclear medicine techniques are also used for treatment, not only diagnosis.

2. What are common nuclear medicine tests?

Common nuclear medicine tests include bone scans, thyroid scans, PET scans, cardiac stress tests, kidney scans, gallbladder scans, and lung ventilation-perfusion scans. Each test uses a different tracer to examine a specific organ system or disease process. For example, a bone scan can detect bone injury or cancer spread, while a thyroid scan can evaluate thyroid nodules or overactivity. The test chosen depends on symptoms, medical history, and what the doctor needs to investigate.

3. What can nuclear medicine detect?

Nuclear medicine can detect many conditions, including heart disease, cancer, bone infection, fractures, thyroid disease, kidney problems, gallbladder dysfunction, and blood flow abnormalities in the lungs. It can also show whether certain organs are working properly. Because these tests measure function, they may reveal disease before structural changes become obvious on other scans. Results are usually interpreted together with symptoms, blood tests, and other imaging findings.

4. Is nuclear medicine safe?

Nuclear medicine is generally considered safe when used appropriately. The radioactive tracer amount is usually small, and it leaves the body over time through urine, stool, or natural radioactive decay. Side effects are uncommon, though some people may have mild discomfort from an injection or rare allergic reactions. Pregnant or breastfeeding patients should tell their healthcare provider before the test because special precautions may be needed.

5. How should I prepare for a nuclear medicine test?

Preparation for a nuclear medicine test depends on the type of scan. Some tests require fasting, avoiding caffeine, stopping certain medications, or drinking extra fluids before or after the procedure. You should tell your healthcare team about pregnancy, breastfeeding, allergies, kidney disease, and all medications or supplements you take. Following instructions carefully helps improve image quality and test accuracy.

6. How long does a nuclear medicine scan take?

The length of a nuclear medicine scan varies by test. Some scans take less than an hour, while others require several hours or delayed images later the same day. In some cases, the tracer needs time to travel to the target organ before imaging begins. Your imaging center will explain the schedule so you know when the tracer is given and when pictures will be taken.

Sources

MedlinePlus. Nuclear Medicine Scans. 
RadiologyInfo.org. Nuclear Medicine, General. 
Cleveland Clinic. Nuclear Medicine Imaging. 
Johns Hopkins Medicine. Nuclear Medicine. 
National Cancer Institute. Positron Emission Tomography and Computed Tomography Scans. 
Society of Nuclear Medicine and Molecular Imaging. About Nuclear Medicine and Molecular Imaging.